27/09/2024 14:00 - 15:30
Online
How a patient-centric approach, data solutions and digital innovations are making a difference

How a patient-centric approach, data solutions and digital innovations are making a difference
IMI project RHAPSODY has identified biomarkers associated with diabetes development and progression, findings that could lead the way to personalised treatments.
At IHI, we are working to turn health research and innovation into real benefits for patients and society.
PharmaLedger's use cases are designed to build the case for the wider adoption of blockchain within the pharma industry.
Treating primary Sjögren’s syndrome poses a particular challenge; the wide range of symptoms has made it difficult to identify what works and what doesn’t. A potential breakthrough...